Guijarro, L.G.; Cano-MartÃnez, D.; Toledo-Lobo, M.V.; Ruiz-Llorente, L.; Chaparro, M.; Guerra, I.; Iborra, M.; Cabriada, J.L.; Bujanda, L.; Taxonera, C.;
et al. Evaluation of AIF-1 (Allograft Inflammatory Factor-1) as a Biomarker of Crohn’s Disease Severity. Biomedicines 2022, 10, 727.
https://doi.org/10.3390/biomedicines10030727
AMA Style
Guijarro LG, Cano-MartÃnez D, Toledo-Lobo MV, Ruiz-Llorente L, Chaparro M, Guerra I, Iborra M, Cabriada JL, Bujanda L, Taxonera C,
et al. Evaluation of AIF-1 (Allograft Inflammatory Factor-1) as a Biomarker of Crohn’s Disease Severity. Biomedicines. 2022; 10(3):727.
https://doi.org/10.3390/biomedicines10030727
Chicago/Turabian Style
Guijarro, Luis G., David Cano-MartÃnez, M. Val Toledo-Lobo, Lidia Ruiz-Llorente, MarÃa Chaparro, Iván Guerra, Marisa Iborra, José Luis Cabriada, Luis Bujanda, Carlos Taxonera,
and et al. 2022. "Evaluation of AIF-1 (Allograft Inflammatory Factor-1) as a Biomarker of Crohn’s Disease Severity" Biomedicines 10, no. 3: 727.
https://doi.org/10.3390/biomedicines10030727
APA Style
Guijarro, L. G., Cano-MartÃnez, D., Toledo-Lobo, M. V., Ruiz-Llorente, L., Chaparro, M., Guerra, I., Iborra, M., Cabriada, J. L., Bujanda, L., Taxonera, C., GarcÃa-Sánchez, V., MarÃn-Jiménez, I., Barreiro-de Acosta, M., Vera, I., MartÃn-Arranz, M. D., Mesonero, F., Sempere, L., Gomollón, F., Hinojosa, J.,
... Hernández-Breijo, B., on behalf of the PREDICROHN Study Group from GETECCU.
(2022). Evaluation of AIF-1 (Allograft Inflammatory Factor-1) as a Biomarker of Crohn’s Disease Severity. Biomedicines, 10(3), 727.
https://doi.org/10.3390/biomedicines10030727